Immunotherapy of cancer

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cy...

Full description

Saved in:
Bibliographic Details
Other Authors: Disis, Mary L. (Editor)
Format: Book
Language:English
Published: Totowa, New Jersey Humana Press 2006
Series:Cancer drug discovery and development
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-334029
005 2023018102946
008 230118t20062006NJU a# #001 deng D
020 # # |a 9781588295644  |q hardback 
020 # # |a 1588295648  |q hardback 
040 # # |a DLC  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QZ 266 
090 0 0 |a QZ266  |b I33 2006 
245 0 0 |a Immunotherapy of cancer  |c edited by Mary L. Disis 
264 # 1 |a Totowa, New Jersey  |b Humana Press  |c 2006 
264 # 4 |c ©2006 
300 # # |a xii, 516 pages  |b illustrations  |c 26 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
490 1 # |a Cancer drug discovery and development 
504 # # |a Includes bibliographical references and index 
520 # # |a Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined 
650 1 2 |a Neoplasm  |x Design 
650 2 2 |a Neoplasms  |x therapy 
700 1 # |a Disis, Mary L.  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=334029 
964 # # |c BOK  |d MD 
998 # # |a 00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2||